Aerie Pharmaceuticals Inc. is a publicly traded, clinical-stage pharmaceutical company focused on the discovery, development and commercialization of first-in-class therapies for the treatment of patients with glaucoma and other diseases of the eye.

Aerie Pharmaceuticals

Pharmaceutical

United States of America

The US pharmaceutical industry is a highly globalized industry, dominated by multinational companies that engage in significant business activity in many countries and whose products are distributed and marketed worldwide. The pharmaceutical industry is developing at an unusually rapid pace. The market for pharmaceuticals is growing persistently, and expenses for drugs will amount to $1.5 trillion globally by 2021. Together with Canada and Mexico, it represents the largest continental pharma market worldwide. Investments in biopharmaceutical innovation are driving contributions to the American economy and solidifying America’s role as a leader in medical innovation. The pharmaceuticals sector is forecasted to grow faster than any other market in the next five years with an emphasis on R&D.

Irvine

California

51-200 Employees

Overall, Aerie Pharmaceuticals receives a 3.5 star rating from anonymous employee reviews. The work environment and career development opportunities are generally positive, with employees reporting a supportive and collaborative atmosphere. However, some reviews mention challenges with management quality, such as lack of communication and micromanagement. Work-life balance seems to be a mixed experience, with some employees feeling overwhelmed and others finding a good balance. Overall, employee satisfaction is decent but not outstanding.

Aerie Pharmaceuticals

#1 Video-Talent Marketplace

Ready to discover your perfect career?